MV Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.78M | Sell |
23,151
-98
| -0.4% | -$11.3K | 0.27% | 67 |
|
|
2025
Q4 | $2.45M | Buy |
23,249
+310
| +1% | +$29.1K | 0.24% | 73 |
|
|
2025
Q3 | $1.93M | Sell |
22,939
-5,656
| -20% | -$466K | 0.18% | 80 |
|
|
2025
Q2 | $2.26M | Sell |
28,595
-1,789
| -6% | -$142K | 0.23% | 75 |
|
|
2025
Q1 | $2.73M | Buy |
30,384
+2,712
| +10% | +$253K | 0.29% | 59 |
|
|
2024
Q4 | $2.75M | Sell |
27,672
-85
| -0.3% | -$8.76K | 0.29% | 65 |
|
|
2024
Q3 | $3.15M | Buy |
27,757
+1,285
| +5% | +$153K | 0.33% | 55 |
|
|
2024
Q2 | $3.28M | Buy |
26,472
+174
| +0.7% | +$22.4K | 0.37% | 50 |
|
|
2024
Q1 | $3.47M | Buy |
26,298
+17,210
| +189% | +$2.12M | 0.4% | 44 |
|
|
2023
Q4 | $991K | Sell |
9,088
-59
| -0.6% | -$6.12K | 0.13% | 84 |
|
|
2023
Q3 | $942K | Buy |
9,147
+67
| +0.7% | +$7.22K | 0.13% | 84 |
|
|
2023
Q2 | $1.05M | Buy |
9,080
+79
| +0.9% | +$8.97K | 0.14% | 78 |
|
|
2023
Q1 | $958K | Buy |
9,001
+241
| +3% | +$26K | 0.13% | 79 |
|
|
2022
Q4 | $972K | Buy |
8,760
+5
| +0.1% | +$511 | 0.15% | 75 |
|
|
2022
Q3 | $754K | Buy |
8,755
+1,519
| +21% | +$136K | 0.13% | 82 |
|
|
2022
Q2 | $660K | Sell |
7,236
-440
| -6% | -$39K | 0.11% | 87 |
|
|
2022
Q1 | $630K | Buy |
7,676
+149
| +2% | +$11.7K | 0.09% | 95 |
|
|
2021
Q4 | $577K | Buy |
7,527
+8
| +0.1% | +$637 | 0.08% | 91 |
|
|
2021
Q3 | $565K | Buy |
7,519
+325
| +5% | +$24.7K | 0.09% | 92 |
|
|
2021
Q2 | $559K | Sell |
7,194
-105
| -1% | -$7.81K | 0.09% | 89 |
|
|
2021
Q1 | $537K | Sell |
7,299
-1,408
| -16% | -$104K | 0.1% | 87 |
|
|
2020
Q4 | $680K | Buy |
8,707
+2,484
| +40% | +$190K | 0.13% | 79 |
|
|
2020
Q3 | $493K | Buy |
6,223
+1,305
| +27% | +$102K | 0.1% | 74 |
|
|
2020
Q2 | $363K | Buy |
4,918
+253
| +5% | +$19K | 0.09% | 76 |
|
|
2020
Q1 | $342K | Buy |
4,665
+1,339
| +40% | +$105K | 0.09% | 76 |
|
|
2019
Q4 | $289K | Sell |
3,326
-16
| -0.5% | -$1.31K | 0.06% | 94 |
|
|
2019
Q3 | $268K | Hold |
3,342
| – | – | 0.06% | 94 |
|
|
2019
Q2 | $267K | Sell |
3,342
-69
| -2% | -$5.28K | 0.06% | 94 |
|
|
2019
Q1 | $271K | Buy |
3,411
+614
| +22% | +$45.9K | 0.07% | 87 |
|
|
2018
Q4 | $204K | Buy |
2,797
+53
| +2% | +$3.74K | 0.06% | 95 |
|
|
2018
Q3 | $186K | Buy |
2,744
+47
| +2% | +$2.99K | 0.05% | 100 |
|
|
2018
Q2 | $156K | Hold |
2,697
| – | – | 0.04% | 109 |
|
|
2018
Q1 | $140K | Hold |
2,697
| – | – | 0.04% | 113 |
|
|
2017
Q4 | $145K | Hold |
2,697
| – | – | 0.04% | 117 |
|
|
2017
Q3 | $165K | Hold |
2,697
| – | – | 0.05% | 106 |
|
|
2017
Q2 | $165K | Hold |
2,697
| – | – | 0.05% | 107 |
|
|
2017
Q1 | $163K | Hold |
2,697
| – | – | 0.05% | 104 |
|
|
2016
Q4 | $151K | Hold |
2,697
| – | – | 0.05% | 103 |
|
|
2016
Q3 | $161K | Sell |
2,697
-1,572
| -37% | -$91.9K | 0.06% | 98 |
|
|
2016
Q2 | $235K | Hold |
4,269
| – | – | 0.09% | 82 |
|
|
2016
Q1 | $216K | Hold |
4,269
| – | – | 0.09% | 82 |
|
|
2015
Q4 | $215K | Hold |
4,269
| – | – | 0.08% | 86 |
|
|
2015
Q3 | $201K | Hold |
4,269
| – | – | 0.09% | 73 |
|
|
2015
Q2 | $232K | Hold |
4,269
| – | – | 0.09% | 68 |
|
|
2015
Q1 | $234K | Sell |
4,269
-124
| -3% | -$7.02K | 0.1% | 61 |
|
|
2014
Q4 | $238K | Buy |
+4,393
| New | +$245K | 0.11% | 56 |
|
Other funds holding MRK
VCM
VPM
MV Capital Management's MRK Position: Q1 2026 in Review
MV Capital Management reduced its Merck (MRK) stake by 0.42% in Q1 2026, selling an estimated $11.3K and leaving 23,151 shares worth $2.78M. The position accounts for 0.27% of the portfolio, ranked #67.
MV Capital Management first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.47M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- MV Capital Management held 23,151 shares of Merck worth $2.78M as of Q1 2026.
- MV Capital Management sold 98 Merck shares in Q1 2026, an estimated $11.3K.
- Merck made up 0.27% of MV Capital Management's portfolio in Q1 2026, its #67 holding.
- MV Capital Management first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
- MV Capital Management's Merck position peaked at $3.47M in Q1 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on MV Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.